海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
7件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Available
- A study to investigate the safety of additional treatment with Vitamin B3 in children with Juvenile Idiopathic Arthritis (JIA)
- Juvenile idiopathic arthritis (JIA);Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Netherlands
- 2017-09-14
Not Available
- A SINGLE CENTER, SINGLE-BLIND, PARALLEL GROUP CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF W0153 VS. STANDARD MOISTURIZER IN THE MAINTENANCE OF PATIENTS WITH ATOPIC DERMATITIS
- Atopic Dermatitis MedDRA version: 9.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis
- United Kingdom
- 2007-05-30
Not Available
- The purpose of this study is to investigate the efficacy and safety of the ibuprofen suspension, developed by Berlin-Chemie AG for oral administration (20 mg/ml and 40 mg/ml) compared to Nurofen® in reducing fever and pain in children at the age of 3-9 years old with uncomplicated acute otitis media.
- Acute otitis media (AOM) is an acute inflammatory disease involving the mucosa of the middle ear. AOM is one of the most frequent complications of upper respiratory tract infections in children. Treatment of AOM requires use of drugs with antipiretic, analgesic and antinflammatory action, as well as antibiotics.;Therapeutic area: Diseases [C] - Symptoms and general pathology [C23]
- Russian Federation, Ukraine
- 2015-12-29
Not Available
- A PHASE II, SINGLE-CENTRE, INVESTIGATOR-BLIND, PARALLEL GROUP CLINICAL TRIAL TO INVESTIGATE THE EFFICACY AND SAFETY OF 1% CICLOPIROX OLAMINE (BATRAFEN® CREAM), COMPARED TO 1% HYDROCORTISONE ACETATE (HC45® CREAM), COMPARED TO A TOPICAL EMOLLIENT (E45® CREAM), IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE ATOPIC ECZEMA
- Mild to moderate atopic eczema MedDRA version: 8.0 Level: LLT Classification code 10003641
- United Kingdom
- 2005-07-01
Not Available
- The CREAM Study - Children with Eczema Antibiotic Management Study
- Atopic Eczema MedDRA version: 14.1 Level: LLT Classification code 10003641 Term: Atopic eczema System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- United Kingdom
- 2012-07-27
Not Available
- An Open-label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AEB1102 in Patients with Arginase I Deficiency
- Arginase 1 deficiency Hyperargininemia MedDRA version: 20.0 Level: PT Classification code 10062695 Term: Arginase deficiency System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Canada, Portugal, United Kingdom, United States
- 2018-10-30
Not Available
- Study to assess the safety and efficacy of CDZ173 in patients with APDS/PASLI
- APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/ p110d-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency);Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Belarus, Czech Republic, Ireland, Netherlands, Russian Federation, United Kingdom, United States
- 2015-01-08
- 1